Dow Down 0.22% Nasdaq Up 0.14%

Agenus Inc. (AGEN)

-NasdaqCM
3.07 Down 0.05(1.60%) Aug 22, 4:00PM EDT
Prev Close:3.12
Open:3.10
Bid:2.94 x 100
Ask:3.58 x 5100
1y Target Est:5.75
Beta:2.16
Next Earnings Date:N/A
Day's Range:3.05 - 3.13
52wk Range:2.27 - 5.27
Volume:491,823
Avg Vol (3m):913,453
Market Cap:192.42M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AGENDown 1.60%192.42M
ABPIDown 4.00%215.41K
DNDNDown 1.86%205.17M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):39.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.52
Quarterly EPS Est (Sep-14) :-0.16
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Agenus Inc., a biopharmaceutical company, is developing a portfolio of immuno-oncology candidates, including checkpoint modulators (CPMs), heat shock protein vaccines, and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback